- Home
- FTHM vs ESLA Comparison
FTHM vs ESLA Comparison
Compare FTHM & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- ESLA
- Stock Information
- Founded
- FTHM 2010
- ESLA 2021
- Country
- FTHM United States
- ESLA United States
- Employees
- FTHM N/A
- ESLA N/A
- Industry
- FTHM Real Estate
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTHM Finance
- ESLA Health Care
- Exchange
- FTHM Nasdaq
- ESLA Nasdaq
- Market Cap
- FTHM 38.3M
- ESLA 35.5M
- IPO Year
- FTHM 2020
- ESLA N/A
- Fundamental
- Price
- FTHM $1.30
- ESLA $0.89
- Analyst Decision
- FTHM Buy
- ESLA Strong Buy
- Analyst Count
- FTHM 1
- ESLA 1
- Target Price
- FTHM $2.50
- ESLA $16.00
- AVG Volume (30 Days)
- FTHM 150.0K
- ESLA 16.0K
- Earning Date
- FTHM 08-12-2025
- ESLA 08-25-2025
- Dividend Yield
- FTHM N/A
- ESLA N/A
- EPS Growth
- FTHM N/A
- ESLA N/A
- EPS
- FTHM N/A
- ESLA N/A
- Revenue
- FTHM $390,032,000.00
- ESLA N/A
- Revenue This Year
- FTHM $32.40
- ESLA N/A
- Revenue Next Year
- FTHM $18.04
- ESLA N/A
- P/E Ratio
- FTHM N/A
- ESLA N/A
- Revenue Growth
- FTHM 19.16
- ESLA N/A
- 52 Week Low
- FTHM $0.65
- ESLA $0.63
- 52 Week High
- FTHM $3.37
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- FTHM 50.06
- ESLA 53.22
- Support Level
- FTHM $1.05
- ESLA $0.82
- Resistance Level
- FTHM $1.50
- ESLA $0.95
- Average True Range (ATR)
- FTHM 0.14
- ESLA 0.05
- MACD
- FTHM 0.00
- ESLA 0.00
- Stochastic Oscillator
- FTHM 35.71
- ESLA 69.88
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.